Results
Filtros
Trump marks 1 year of government with historic shift in medicinal cannabis
President advances in the medicinal agenda and targets elderly electorate with CBD in Medicare, but signs law that threatens hemp market
When discussing medical cannabis, Trump states: “I don’t want to, but many people need it”
Trump states he does not intend to use medical cannabis, but acknowledges that the substance can be an alternative to opioids and necessary for many patients.
Trump reclassifies cannabis in the USA and recognizes medicinal use at the federal level; Check out the analysis
Move from Schedule I to Schedule III could unlock research, ease fiscal obstacles, and impact state markets
Shiitake mushroom could become a living and sustainable chip, say researchers
Technology inspired by fungi promises cultivated and sustainable chips
Trump supports bill that restricts THC in hemp and divides the sector in the US
Proposal redefining limits and banning derivatives with total THC advances in the Senate with White House support
Full legalization of cannabis gains momentum in the US and puts pressure on Trump
Organizations are pressuring President Trump to legalize marijuana in the US, going beyond mere rescheduling and seeking to repair the damages of historical prohibition
How U.S. cannabis brands are protecting their intellectual property ahead of legalization
Experts point out that federal legalization could open doors for national trademarks, but obstacles still persist
Thanksgiving Cannabis Tradition Gains Space in Major Media Outlets and Industry
Habit of consuming cannabis on the "Cousin's Walk" is no longer a family secret and becomes the focus of media and commerce in the USA
With inspirations ranging from American bluegrass to Gabriel García Márquez literature, entrepreneur points to "mirror" market for Brazil
The Australian medicinal cannabis market is consolidating as an international reference and inspiring discussions in Brazil
Use of Psychedelics to be Monitored in the US Armed Forces
The US Department of Defense will start testing military personnel for psilocybin, a psychedelic substance found in mushrooms, aiming at the safety, discipline, and readiness of the armed forces
Trump considers reclassifying marijuana as lower-risk drug
The Trump administration is considering reclassifying marijuana as a lower-risk drug, a move that would facilitate research, investments, and tax deductions for the sector
CBD Cream: Everything You Need to Know About the Topical Product
With direct application to the skin, CBD cream offers localized therapeutic effects, being a safe alternative for muscle pain, inflammation, and dermatological problems
Market movement in cannabis grows with advancement of reclassification in the US
Federal reclassification drives mergers and acquisitions in the US cannabis sector
Study shows cannabis users have enhanced cognitive abilities
Large-scale study funded by the US government reveals that older adults who use cannabis have superior brain performance and possible neuroprotective benefits
Marijuana May Leave List of Highly Harmful Substances to Health in the U.S.
Drug Enforcement Administration (DEA) will adjust the classification, moving the plant from Schedule I to Schedule III. 'Historical reparation,' says expert
Arrival of gummies sparks debate on expanding medical cannabis in the U.S.
Measure comes as the state government pressures the Legislature to include new diseases in the program
Wisconsin Discusses New Proposal for Cannabis Legalization and Medical Use
Proposal announced by Democrats provides for adult and medical use of cannabis, as well as the creation of a regulatory body in the state.
Illinois Releases New Update on Cannabis Sales in 2025
Data released by the state shows monthly fluctuations and a decline in annual sales volume
Uruguay Emerges as Leading Hemp Hub After Stringent Restrictions in the US
American measure rendering full spectrum extracts unfeasible has a long transition period, but already positions Uruguay as a new strategic export alternative
Law ending shutdown may alter the hemp industry in the US
New spending law in the US, which ended the shutdown, may impact the market of psychoactive hemp derivatives